# The Effectiveness of Photobiomodulation Therapy on Pain and Function in Patients with Patellofemoral Pain Syndrome—A Systematic Review and Meta-Analysis

**Authors:** Mohamed Salaheldien Alayat, Roaa A. Sroge, Abdulaziz Awali, Ammar Fadil, Omair Belal Malibari, Raad Hatim Ajawi, Eyad Noor Wali, Suhail Hafiz, Sameer Yamani

PMC · DOI: 10.3390/jcm15010020 · Journal of Clinical Medicine · 2025-12-19

## TL;DR

This study finds that photobiomodulation therapy can reduce pain and improve function in people with patellofemoral pain syndrome, but more high-quality research is needed.

## Contribution

The paper provides a systematic review and meta-analysis of photobiomodulation's effectiveness for patellofemoral pain syndrome.

## Key findings

- Photobiomodulation significantly reduced pain compared to control groups.
- Functional outcomes improved with photobiomodulation, though with high heterogeneity.
- Study quality was low, limiting confidence in the results.

## Abstract

Objectives: The aim of this systematic review was to evaluate the effectiveness of photobiomodulation (PBM) on pain and function in individuals with Patellofemoral Pain Syndrome (PFPS). Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. Search was performed across PubMed/Midline, Scopus, Web of Science, EBSCO, ScienceDirect, Wiley Online Library, Springer, Cochrane CENTRAL, PEDro, ResearchGate, and Google Scholar from inception to January 2025. Randomized controlled trials (RCT) examining PBM in individuals with PFPS were included. Data extraction, risk-of-bias assessment (RoB 2), and quality of evidence evaluation (GRADE) were performed independently by multiple reviewers. Primary and secondary outcomes were pain and function, respectively. A random effect meta-analysis was performed to estimate the standardized mean difference (SMD) at 95% confidence interval (CI) and overall effect size. Results: Eight trials (340 participants) met the inclusion criteria. PBM significantly reduced pain compared with the control (SMD = −0.83; 95% CI −1.40 to −0.27). Functional outcomes demonstrated a significant improvement favoring PBM (SMD = 0.68; 95% CI 0.08 to 1.27), although substantial heterogeneity was present (I2 = 83%). RoB2 showed five high-risk studies. GRADE showed a very low quality of evidence due to study limitations, imprecision, and inconsistency which limit the confidence to the effect estimate. Conclusions: PBM, combined with exercise, provides improvements in pain and knee function in individuals with PFPS. While findings support PBM as an effective adjunct modality, standardized dosing protocols and larger, high-quality RCTs are needed to strengthen future clinical recommendations.

## Linked entities

- **Diseases:** Patellofemoral Pain Syndrome (MONDO:0006894)

## Full-text entities

- **Diseases:** Pain (MESH:D010146), PFPS (MESH:D046788)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12786645/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12786645/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12786645/full.md

---
Source: https://tomesphere.com/paper/PMC12786645